Novel Insights into Osteoclast Energy Metabolism
- PMID: 37816910
- PMCID: PMC10724336
- DOI: 10.1007/s11914-023-00825-3
Novel Insights into Osteoclast Energy Metabolism
Abstract
Purpose of review: Osteoclasts are crucial for the dynamic remodeling of bone as they resorb old and damaged bone, making space for new bone. Metabolic reprogramming in these cells not only supports phenotypic changes, but also provides the necessary energy for their highly energy-consuming activity, bone resorption. In this review, we highlight recent developments in our understanding of the metabolic adaptations that influence osteoclast behavior and the overall remodeling of bone tissue.
Recent findings: Osteoclasts undergo metabolic reprogramming to meet the energy demands during their transition from precursor cells to fully mature bone-resorbing osteoclasts. Recent research has made considerable progress in pinpointing crucial metabolic adaptations and checkpoint proteins in this process. Notably, glucose metabolism, mitochondrial biogenesis, and oxidative respiration were identified as essential pathways involved in osteoclast differentiation, cytoskeletal organization, and resorptive activity. Furthermore, the interaction between these pathways and amino acid and lipid metabolism adds to the complexity of the process. These interconnected processes can function as diverse fuel sources or have independent regulatory effects, significantly influencing osteoclast function. Energy metabolism in osteoclasts involves various substrates and pathways to meet the energetic requirements of osteoclasts throughout their maturation stages. This understanding of osteoclast biology may provide valuable insights for modulating osteoclast activity during the pathogenesis of bone-related disorders and may pave the way for the development of innovative therapeutic strategies.
Keywords: Bioenergetics; Glycolysis; Mitochondria; Osteoclasts; Oxidative phosphorylation.
© 2023. The Author(s).
Conflict of interest statement
MR reports honoraria for lectures from UCB and Vifor Pharma. LH reports honoraria for advisory boards from Amgen, UCB, and Ascendis to his institution and himself. MGLC, VP, and FL declare no competing interests.
Figures


Similar articles
-
Metabolic reprogramming in osteoclasts.Semin Immunopathol. 2019 Sep;41(5):565-572. doi: 10.1007/s00281-019-00757-0. Epub 2019 Sep 24. Semin Immunopathol. 2019. PMID: 31552471 Free PMC article. Review.
-
Impact of the SIK3 pathway inhibition on osteoclast differentiation via oxidative phosphorylation.J Bone Miner Res. 2024 Sep 2;39(9):1340-1355. doi: 10.1093/jbmr/zjae105. J Bone Miner Res. 2024. PMID: 39030684
-
From macrophage to osteoclast - How metabolism determines function and activity.Cytokine. 2018 Dec;112:102-115. doi: 10.1016/j.cyto.2018.06.013. Epub 2018 Jun 18. Cytokine. 2018. PMID: 29914791 Review.
-
Both aerobic glycolysis and mitochondrial respiration are required for osteoclast differentiation.FASEB J. 2020 Aug;34(8):11058-11067. doi: 10.1096/fj.202000771R. Epub 2020 Jul 6. FASEB J. 2020. PMID: 32627870
-
A Zeb1/MtCK1 metabolic axis controls osteoclast activation and skeletal remodeling.EMBO J. 2023 Apr 3;42(7):e111148. doi: 10.15252/embj.2022111148. Epub 2023 Feb 27. EMBO J. 2023. PMID: 36843552 Free PMC article.
Cited by
-
Osteoclast-derived arachidonic acid triggers dormant lung adenocarcinoma cell activation.iScience. 2025 Mar 26;28(5):112167. doi: 10.1016/j.isci.2025.112167. eCollection 2025 May 16. iScience. 2025. PMID: 40271019 Free PMC article.
-
A multidimensional analysis of temporomandibular joint and ankle joint erosion in inflammatory arthritis.Front Immunol. 2025 Jul 18;16:1560723. doi: 10.3389/fimmu.2025.1560723. eCollection 2025. Front Immunol. 2025. PMID: 40755771 Free PMC article.
-
Resistance and Aerobic Preconditioning Delays Unloading-Induced Multisystemic Physiological Changes: The NEBULA Project.FASEB J. 2025 Jul 15;39(13):e70759. doi: 10.1096/fj.202501128R. FASEB J. 2025. PMID: 40614062 Free PMC article.
-
Identification and experimental validation of programmed cell death- and mitochondria-associated biomarkers in osteoporosis and immune microenvironment.Front Genet. 2024 Jul 26;15:1439171. doi: 10.3389/fgene.2024.1439171. eCollection 2024. Front Genet. 2024. PMID: 39130750 Free PMC article.
-
The glycolytic enzyme PKM2 regulates inflammatory osteoclastogenesis by modulating STAT3 phosphorylation.J Biol Chem. 2025 Apr;301(4):108389. doi: 10.1016/j.jbc.2025.108389. Epub 2025 Mar 6. J Biol Chem. 2025. PMID: 40057191 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials